Biogen Inc.
BIIB
$129.44
$3.853.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.82B | 9.68B | 9.61B | 9.67B | 9.66B |
| Total Other Revenue | -- | -- | -- | -- | -20.70M |
| Total Revenue | 9.82B | 9.68B | 9.61B | 9.67B | 9.66B |
| Cost of Revenue | 2.30B | 2.22B | 2.26B | 2.28B | 2.37B |
| Gross Profit | 7.51B | 7.45B | 7.35B | 7.39B | 7.29B |
| SG&A Expenses | 2.38B | 2.38B | 2.31B | 2.49B | 2.48B |
| Depreciation & Amortization | 420.00M | 386.50M | 372.10M | 302.70M | 268.70M |
| Other Operating Expenses | 246.90M | 254.40M | 251.60M | 232.80M | 227.30M |
| Total Operating Expenses | 7.29B | 7.20B | 7.20B | 7.51B | 7.67B |
| Operating Income | 2.52B | 2.47B | 2.41B | 2.17B | 2.00B |
| Income Before Tax | 1.75B | 1.91B | 1.91B | 1.31B | 1.32B |
| Income Tax Expenses | 273.10M | 273.80M | 291.70M | 156.30M | 156.00M |
| Earnings from Continuing Operations | 1.48K | 1.63K | 1.61K | 1.16K | 1.17K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 800.00K | 1.00M | -700.00K |
| Net Income | 1.48B | 1.63B | 1.62B | 1.16B | 1.17B |
| EBIT | 2.52B | 2.47B | 2.41B | 2.17B | 2.00B |
| EBITDA | 3.23B | 3.15B | 3.04B | 2.74B | 2.53B |
| EPS Basic | 10.15 | 11.21 | 11.11 | 7.97 | 8.05 |
| Normalized Basic EPS | 10.29 | 9.97 | 9.34 | 8.62 | 8.20 |
| EPS Diluted | 10.12 | 11.18 | 11.07 | 7.94 | 8.01 |
| Normalized Diluted EPS | 10.27 | 9.94 | 9.30 | 8.59 | 8.17 |
| Average Basic Shares Outstanding | 583.10M | 582.20M | 581.40M | 580.50M | 579.60M |
| Average Diluted Shares Outstanding | 584.70M | 584.00M | 583.60M | 582.30M | 581.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |